WCM
DGX icon

Wealthcare Capital Management’s Quest Diagnostics DGX Stock Holding History

Wealthcare Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35
Closed -$4K – 222
2021
Q1 		$4K Buy
+35
New +$4.31K ﹤0.01% 412

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wealthcare Capital Management's DGX Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Quest Diagnostics (DGX) in Q2 2021, closing a stake of 35 shares — an estimated $4K sold.

Wealthcare Capital Management first reported a position in DGX in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 814 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

  • Wealthcare Capital Management reported no remaining Quest Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Capital Management sold 35 Quest Diagnostics shares in Q2 2021, an estimated $4K.
  • Wealthcare Capital Management first reported a position in Quest Diagnostics in Q1 2021 and held it in 1 quarter.
  • Wealthcare Capital Management's Quest Diagnostics position peaked at $4K in Q1 2021.
  • 814 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.